NF-kB activation inhibitor   Click here for help

GtoPdb Ligand ID: 6012

Synonyms: AG-F-89549 | EVP4593
Compound class: Synthetic organic
Comment: This compound potently inhibits nuclear factor-κB (NFκB) activation and LPS-induced TNFα production [7]. Its discovery is reported in [7] where it is compound 11q.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 73.06
Molecular weight 356.16
XLogP 3.99
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES Nc1ccc2c(c1)c(NCCc1ccc(cc1)Oc1ccccc1)ncn2
Isomeric SMILES Nc1ccc2c(c1)c(NCCc1ccc(cc1)Oc1ccccc1)ncn2
InChI InChI=1S/C22H20N4O/c23-17-8-11-21-20(14-17)22(26-15-25-21)24-13-12-16-6-9-19(10-7-16)27-18-4-2-1-3-5-18/h1-11,14-15H,12-13,23H2,(H,24,25,26)
InChI Key IBAKVEUZKHOWNG-UHFFFAOYSA-N
References
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Baeuerle PA, Baltimore D. (1996)
NF-kappa B: ten years after.
Cell, 87 (1): 13-20. [PMID:8858144]
3. Baeuerle PA, Henkel T. (1994)
Function and activation of NF-kappa B in the immune system.
Annu Rev Immunol, 12: 141-79. [PMID:8011280]
4. Blackwell TS, Christman JW. (1997)
The role of nuclear factor-kappa B in cytokine gene regulation.
Am J Respir Cell Mol Biol, 17 (1): 3-9. [PMID:9224203]
5. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013)
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Biochem J, 451 (2): 313-28. [PMID:23398362]
6. May MJ, Ghosh S. (1998)
Signal transduction through NF-kappa B.
Immunol Today, 19 (2): 80-8. [PMID:9509763]
7. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T, Hayashi H. (2003)
Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation.
Bioorg Med Chem, 11 (3): 383-91. [PMID:12517433]
8. Vossen AC, Savelkoul HF. (1994)
Cytokines in clinical and experimental transplantation.
Mediators Inflamm, 3 (6): 403-10. [PMID:18475587]
9. Wu J, Shih HP, Vigont V, Hrdlicka L, Diggins L, Singh C, Mahoney M, Chesworth R, Shapiro G, Zimina O et al.. (2011)
Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.
Chem Biol, 18 (6): 777-93. [PMID:21700213]